Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 3, 2025 • 9:31 AM ET

Date/Time Source News Release
06/02/2025 07:00 AM EDT GlobeNewswire Instil Bio Announces Appointment of Jamie Freedman, M.D., Ph.D., as Chief Medical Officer
05/30/2025 07:00 AM EDT GlobeNewswire Instil Bio to Participate in the 2025 Jefferies Global Healthcare Conference
05/23/2025 07:00 AM EDT GlobeNewswire Instil Bio and ImmuneOnco to Host Investor and Analyst Breakfast to Discuss the Evolving PD-(L)1xVEGF Bispecific Antibody Landscape and Clinical Trial Updates During the 2025 ASCO Annual Meeting in Chicago
05/13/2025 07:00 AM EDT GlobeNewswire Instil Bio Reports First Quarter 2025 Financial Results and Provides Corporate Update
03/04/2025 07:09 AM EST GlobeNewswire Instil Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
01/14/2025 07:00 AM EST GlobeNewswire Instil Bio Announces Clinical Progress in China for IMM2510/SYN-2510, a Clinical-Stage PD-L1xVEGF Bispecific Antibody
11/13/2024 07:00 AM EST GlobeNewswire Instil Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Page
  • 1

Additional News

As of June 3, 2025 • 9:31 AM ET

Date/Time Source News Release
06/02/2025 11:46 AM EDT Zacks Summit Therapeutics Stock Nosedives on Mixed NSCLC Study Results
06/02/2025 07:50 AM EDT SeekingAlpha Instil Bio appoints Jamie Freedman as Chief Medical Officer
05/29/2025 12:00 PM EDT Zacks Instil Bio (TIL) Upgraded to Buy: What Does It Mean for the Stock?
05/29/2025 09:55 AM EDT Zacks Wall Street Analysts Believe Instil Bio (TIL) Could Rally 343.63%: Here's is How to Trade
05/26/2025 09:48 PM EDT Stock Traders Daily (TIL) Proactive Strategies
05/26/2025 01:07 AM EDT SeekingAlpha Investing In The Promising PD1/VEGF Bispecific - Pfizer And Instil Could Be Good Candidates
05/25/2025 07:09 AM EDT SeekingAlpha Instil Bio: Second-Half 2025 AXN-2510 Data Could Mark Another PD-1/VEGF Success
05/22/2025 11:31 AM EDT SeekingAlpha Instil Bio shares rise on immunotherapy trial updates
05/13/2025 08:48 AM EDT SeekingAlpha Instil Bio Non-GAAP EPS of -$1.32
05/10/2025 05:31 AM EDT US Earnings Reports Expected earnings - Instil Bio Inc.
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.